Figure 1.
Age-specific temporal trends in human papillomavirus virus (HPV) vaccine coverage among females and males aged 9–26 years, National Health and Nutrition Examination Surveys, 2011–2016. A and B, Data for female (A) and male (B) participants. The percentages of females and males who reported previously receiving ≥1, ≥2, and 3 HPV vaccine doses are shown by age group and survey period. ***P ≤ .05 for linear trend across the 3 survey periods.